Home > Cashflow Statement > GENPHARMASEC

GENPHARMASEC
Cashflow Statement

GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023
Profit Before Tax₹1.88 Cr₹0.25 Cr₹0.28 Cr
Adjustment ₹-1.04 Cr₹0.39 Cr₹0.16 Cr
Changes In working Capital ₹2.22 Cr₹-3.54 Cr₹-3.77 Cr
Cash Flow after changes in Working Capital ₹3.06 Cr₹-2.90 Cr₹-3.32 Cr
Cash Flow from Operating Activities ₹2.99 Cr₹-2.95 Cr₹-3.06 Cr
Cash Flow from Investing Activities ₹-15 Cr₹-28 Cr₹0.36 Cr
Cash Flow from Financing Activities ₹-1.25 Cr₹48 Cr₹3.08 Cr
Net Cash Inflow / Outflow ₹-14 Cr₹17 Cr₹0.39 Cr
Opening Cash & Cash Equivalents ₹19 Cr₹1.99 Cr₹1.61 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ---
Cash & Cash Equivalent of Subsidiaries under liquidations ---
Translation adjustment on reserves / op cash balalces frgn subsidiaries ---
Effect of Foreign Exchange Fluctuations ---
Closing Cash & Cash Equivalent ₹5.27 Cr₹19 Cr₹1.99 Cr

Compare Cashflow Statement of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹51.5 Cr 2.2% -28.5% -60.6% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,134.9 Cr 0.3% -12.1% -22.7% Stock Analytics
KIRI INDUSTRIES ₹2,189.3 Cr -0.2% -20% -47.7% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,496.6 Cr 7.5% -2.8% -36.8% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,033.8 Cr 10.7% 1% 5.8% Stock Analytics
BODAL CHEMICALS ₹683.6 Cr -1.3% 17.5% -17.3% Stock Analytics


GENPHARMASEC Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

2.2%

-28.5%

-60.6%

SENSEX

0.6%

-11.1%

-6.2%


You may also like the below Video Courses